Drug Profile
AR 1006
Alternative Names: AR1006Latest Information Update: 28 Jul 2020
Price :
$50
*
At a glance
- Originator AriBio
- Class
- Mechanism of Action Endoplasmin modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Systemic lupus erythematosus
Most Recent Events
- 28 Jul 2020 No recent reports of development identified for research development in Systemic-lupus-erythematosus in South Korea
- 01 Jun 2016 Early research in Systemic lupus erythematosus in South Korea (unspecified route)